
MSD’s Keytruda significantly improved overall survival (OS) compared to chemotherapy in people with lung cancer and PD-L1 expression, a trial …

Eli Lilly’s lung cancer drug Cyramza (ramucirumab) has been shown the green light by the US Food and Drug Administration …
The EMA has issued a positive opinion for the approval of Boehringer Ingelheim’s nintedanib in combination with docetaxel for the …
Research showing the effectiveness of established cancer treatments in new settings is taking centre stage at this year’s American Society …

Roche’s Avastin will remain on the market as a treatment for breast cancer, but only in combination with paclitaxel, the …